Compare GCT & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GCT | TNDM |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2021 | 2013 |
| Metric | GCT | TNDM |
|---|---|---|
| Price | $45.22 | $19.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 18 |
| Target Price | ★ $33.00 | $28.33 |
| AVG Volume (30 Days) | 564.9K | ★ 1.8M |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.70 | N/A |
| EPS | ★ 3.59 | N/A |
| Revenue | ★ $1,161,042,000.00 | $1,014,736,000.00 |
| Revenue This Year | $14.43 | $8.01 |
| Revenue Next Year | $6.78 | $12.14 |
| P/E Ratio | $11.57 | ★ N/A |
| Revenue Growth | ★ 64.96 | 7.93 |
| 52 Week Low | $11.17 | $10.00 |
| 52 Week High | $48.00 | $29.65 |
| Indicator | GCT | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 35.20 |
| Support Level | $37.95 | $17.71 |
| Resistance Level | $48.00 | $21.89 |
| Average True Range (ATR) | 2.26 | 1.31 |
| MACD | -0.01 | -0.54 |
| Stochastic Oscillator | 97.54 | 3.87 |
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.